ZENBEKEBI Trademark

Trademark Overview


On Tuesday, July 23, 2024, a trademark application was filed for ZENBEKEBI with the United States Patent and Trademark Office. The USPTO has given the ZENBEKEBI trademark a serial number of 98662461. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 12, 2025. This trademark is owned by Celgene Corporation. The ZENBEKEBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for human use.
zenbekebi

General Information


Serial Number98662461
Word MarkZENBEKEBI
Filing DateTuesday, July 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events


Event DateEvent Description
Tuesday, July 23, 2024NEW APPLICATION ENTERED
Monday, February 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 11, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NON-FINAL ACTION WRITTEN